HIF1A and breast cancer: By modulating the expression of a series of glycolytic enzyme genes, HIF-1α could stimulate angiogenesis, enhance aerobic glycolysis, and mediate metabolic reprogramming, which in turn facilitates BC cell malignant transformation (Wilson, 2011).